BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34882832)

  • 1. FGD5 regulates endothelial cell PI3 kinase-β to promote neo-angiogenesis.
    Azad AK; Farhan MA; Murray CR; Suzuki K; Eitzen G; Touret N; Moore RB; Murray AG
    FASEB J; 2022 Jan; 36(1):e22080. PubMed ID: 34882832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling.
    Farhan MA; Azad AK; Touret N; Murray AG
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facio-genital dysplasia-5 regulates matrix adhesion and survival of human endothelial cells.
    Nakhaei-Nejad M; Haddad G; Zhang QX; Murray AG
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2694-701. PubMed ID: 22922960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.
    Song ZY; Wang F; Cui SX; Qu XJ
    Cancer Invest; 2018 Jan; 36(1):10-18. PubMed ID: 29381400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGD5 mediates proangiogenic action of vascular endothelial growth factor in human vascular endothelial cells.
    Kurogane Y; Miyata M; Kubo Y; Nagamatsu Y; Kundu RK; Uemura A; Ishida T; Quertermous T; Hirata K; Rikitake Y
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):988-96. PubMed ID: 22328776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGD5 sustains vascular endothelial growth factor A (VEGFA) signaling through inhibition of proteasome-mediated VEGF receptor 2 degradation.
    Heldin J; O'Callaghan P; Hernández Vera R; Fuchs PF; Gerwins P; Kreuger J
    Cell Signal; 2017 Dec; 40():125-132. PubMed ID: 28927665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VE-PTP inhibition stabilizes endothelial junctions by activating FGD5.
    Braun LJ; Zinnhardt M; Vockel M; Drexler HC; Peters K; Vestweber D
    EMBO Rep; 2019 Jul; 20(7):e47046. PubMed ID: 31267715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial Cell mTOR Complex-2 Regulates Sprouting Angiogenesis.
    Farhan MA; Carmine-Simmen K; Lewis JD; Moore RB; Murray AG
    PLoS One; 2015; 10(8):e0135245. PubMed ID: 26295809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
    Zhu GS; Tang LY; Lv DL; Jiang M
    Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamines facilitate VEGF-dependent angiogenesis via β2-adrenoceptor-induced Epac1 and PKA activation.
    Garg J; Feng YX; Jansen SR; Friedrich J; Lezoualc'h F; Schmidt M; Wieland T
    Oncotarget; 2017 Jul; 8(27):44732-44748. PubMed ID: 28512254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
    Wang J; Yang L; Liang F; Chen Y; Yang G
    J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinase class II α-isoform PI3K-C2α is required for transforming growth factor β-induced Smad signaling in endothelial cells.
    Aki S; Yoshioka K; Okamoto Y; Takuwa N; Takuwa Y
    J Biol Chem; 2015 Mar; 290(10):6086-105. PubMed ID: 25614622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of endothelial cell phosphoinositide 3-kinase β inhibits tumor angiogenesis and tumor growth.
    Azad AK; Zhabyeyev P; Vanhaesebroeck B; Eitzen G; Oudit GY; Moore RB; Murray AG
    Oncogene; 2020 Oct; 39(41):6480-6492. PubMed ID: 32879446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.
    Namkoong S; Kim CK; Cho YL; Kim JH; Lee H; Ha KS; Choe J; Kim PH; Won MH; Kwon YG; Shim EB; Kim YM
    Cell Signal; 2009 Jun; 21(6):906-15. PubMed ID: 19385062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 (P-Rex-1), a guanine nucleotide exchange factor for Rac, mediates angiogenic responses to stromal cell-derived factor-1/chemokine stromal cell derived factor-1 (SDF-1/CXCL-12) linked to Rac activation, endothelial cell migration, and in vitro angiogenesis.
    Carretero-Ortega J; Walsh CT; Hernández-García R; Reyes-Cruz G; Brown JH; Vázquez-Prado J
    Mol Pharmacol; 2010 Mar; 77(3):435-42. PubMed ID: 20018810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis.
    Del Galdo S; Vettel C; Heringdorf DM; Wieland T
    Cell Signal; 2013 Dec; 25(12):2478-84. PubMed ID: 23993968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma.
    Di J; Gao K; Qu D; Yang J; Zheng J
    Tumour Biol; 2017 Jul; 39(7):1010428317701653. PubMed ID: 28691643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
    Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
    Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endosomal RIN2/Rab5C machinery prevents VEGFR2 degradation to control gene expression and tip cell identity during angiogenesis.
    Kempers L; Wakayama Y; van der Bijl I; Furumaya C; De Cuyper IM; Jongejan A; Kat M; van Stalborch AD; van Boxtel AL; Hubert M; Geerts D; van Buul JD; de Korte D; Herzog W; Margadant C
    Angiogenesis; 2021 Aug; 24(3):695-714. PubMed ID: 33983539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.